Emerging roles for the CD36 scavenger receptor as a potential therapeutic target for corneal neovascularization. [electronic resource]
- Endocrine, metabolic & immune disorders drug targets Dec 2008
- 255-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review